Skip to main content
ImmuneCited

Vitamin C 관련 Upper Respiratory Tract Infections

B

Research suggests regular vitamin C supplementation may reduce cold duration by approximately 8% in adults and 14% in children. Supplementation at 1g+/day is associated with reduced severity of cold symptoms. Notably, vitamin C started after symptom onset does not appear to be effective.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dvitamin\u002Dc\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Research suggests regular vitamin C supplementation may reduce cold duration by approximately 8% in adults and 14% in children. Supplementation at 1g+/day is associated with reduced severity of cold symptoms. Notably, vitamin C started after symptom onset does not appear to be effective.

Key Study Findings

Review
UCI Sports Nutrition Project: The Role of Nutrition in the Prevention and Management of Illnesses …
Dose: None vs: None Outcome: None 효과: None None

대상 집단: Elite/professional cyclists nutrition review

Review
Micronutrient Deficiencies in Pediatric IBD: How Often, Why, and What to Do?
Dose: None vs: None Outcome: Micronutrient deficiency management in pediatric IBD 효과: None None

대상 집단: Children with inflammatory bowel disease (review)

Other
Circulating micronutrient levels and respiratory infection susceptibility and severity: a bidirectional Mendelian randomization analysis.
Dose: 12 circulating micronutrients vs: Genetic instrument comparison Outcome: URTI, LRTI, pneumonia risk 효과: None None

대상 집단: Large genetic cohort (MR analysis)

Review
Nutraceuticals and pharmacological to balance the transitional microbiome to extend immunity during COVID-19 and other …
Dose: Probiotics, nutraceuticals vs: None Outcome: Immune response modulation in COVID-19 효과: None None

대상 집단: COVID-19 patients with gut dysbiosis

Randomized Controlled Trial
Zinc and L-Ascorbic Acid Dietary Supplementation Affected Antioxidant Status, Heat Shock Protein 70, and Some …
Dose: None vs: Basal diet without supplementation Outcome: Antioxidant status, hematology, growth in broilers 효과: None None

대상 집단: Broiler chickens

Randomized Controlled Trial n=171 24 weeks Double-blind
Probiotics with vitamin C for the prevention of upper respiratory tract symptoms in children aged …
Dose: 12.5 billion cfu/d vs: placebo Outcome: None 효과: or 6 P=0.0300

대상 집단: None

Key Statistics

30

연구

10000

참여자

Positive

B

등급

Referenced Papers

World journal of … 2015 62 인용
European journal of … 2012 225 인용
American family physician 2012
Clinical evidence 2003
Clinical evidence 2003
The British journal … 2002 358 인용
American family physician 2002
Canadian journal of … 2001 72 인용
Medicine and science … 2000 262 인용
Medicine and science … 2000 248 인용
Alternative medicine review … 2000
Canadian journal of … 1998 41 인용
Journal of applied … 1997 434 인용
International journal of … 1997 167 인용
Scandinavian journal of … 1977 56 인용

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
75-90 mg/day
acuteillness:
1,000-2,000 mg/day
immunesupport:
200-1,000 mg/day

상한량: 2,000 mg/day

연구에서 사용된 용량

용량 기간 효과 N
None -- Mixed --
None -- Neutral --
12 circulating micronutrients -- Mixed --
Probiotics, nutraceuticals -- Positive --
None -- Positive --
12.5 billion cfu/d 24 weeks Mixed 171
45% 988 weeks Positive 26282
None 13.0 weeks Mixed 3135

권장 복용 시간: With meals; divide doses >500 mg for better absorption

Safety & Side Effects

보고된 부작용

  • Gastrointestinal distress (nausea, diarrhea, cramps) at high doses
  • Increased risk of kidney stones in susceptible individuals
  • Interference with certain lab tests (glucose, occult blood)
  • Iron overload risk in hemochromatosis patients

알려진 상호작용

  • Enhances non-heme iron absorption (beneficial or harmful depending on iron status)
  • High doses may reduce effectiveness of certain chemotherapy agents
  • May interfere with anticoagulant therapy (warfarin) at high doses
  • Aluminum-containing antacids (increased aluminum absorption)

일일 최대 섭취 허용량: 2,000 mg/day

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Vitamin C help with Upper Respiratory Tract Infections?
Based on 30 studies with 10,000 participants, there is moderate evidence from clinical studies that Vitamin C may support Upper Respiratory Tract Infections management. Our evidence grade is B (Good Evidence).
How much Vitamin C should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 75-90 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Vitamin C?
Reported side effects may include Gastrointestinal distress (nausea, diarrhea, cramps) at high doses, Increased risk of kidney stones in susceptible individuals, Interference with certain lab tests (glucose, occult blood), Iron overload risk in hemochromatosis patients. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Vitamin C and Upper Respiratory Tract Infections?
We rate the evidence as Grade B (Good Evidence). This rating is based on 30 peer-reviewed studies with 10,000 total participants. The overall direction of effect is positive.

Related Evidence

관련 다른 성분: Upper Respiratory Tract Infections

Vitamin C 다른 건강 상태에 대한 근거

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.